SB 606Session 2026
relative to insurance coverage for biomarker testing.
Progress
- Introduced
- In committee
- Passed Senate
- Passed legislature Not yet
- Sent to governor Not yet
- Became law Not yet
Legislative history
-
House
Interim Study Report: Not Recommended for Future Legislation 10/15/2026 (Vote 11-0; )
-
House
Executive Session: 10/14/2026 10:00 am GP 229
-
House
Subcommittee Work Session: 09/09/2026 10:00 am GP 229
-
House
Refer for Interim Study: MA VV 05/14/2026 HJ 13 P. 9
-
House
Committee Report: Refer for Interim Study 04/29/2026 (Vote 15-0; CC) HC 19 P. 8
-
House
Subcommittee Work Session: 04/28/2026 10:00 am GP 229
-
House
Executive Session: 04/29/2026 10:00 am GP 229
-
House
Subcommittee Work Session: 04/22/2026 10:00 am GP 229
-
House
Subcommittee Work Session: 04/08/2026 10:00 am GP 229
-
House
Public Hearing: 04/01/2026 11:00 am GP 229
-
House
Introduced (in recess of) 03/12/2026 and referred to Commerce and Consumer Affairs HJ 8 P. 114
-
Senate
Ought to Pass: MA, VV; OT3rdg; 03/12/2026; SJ 6
-
Senate
Committee Report: Ought to Pass, 03/12/2026; Vote 7-0; CC; SC 9
-
Senate
Ought to Pass with Amendment #2026-0689s, MA, VV; Refer to Finance Rule 4-5; 02/19/2026; SJ 4
-
Senate
Committee Amendment # 2026-0689s, AA, VV; 02/19/2026; SJ 4
-
Senate
Committee Report: Ought to Pass with Amendment # 2026-0689s, 02/19/2026; Vote 5-0; CC; SC 6
-
Senate
Hearing: 01/28/2026, Room 100, SH, 09:00 am; SC 3
-
Senate
Introduced 01/07/2026 and Referred to Health and Human Services; SJ 1